Hi, everybody. Sheryl Ackison here. Welcome to another edition of the Cheryl

Ackison podcast. Today, blindness risk from Ozempic and Wigovey mirrors that of Viagra. A new study finds a concerning increase in

risk of blindness with popular simiglutides. And I have a backstory. I bet you've never heard.

This episode is brought to you by Shopify. Looking to start a side hustle or become your

own boss, do it with Shopify.

Whether you're selling succulents or stilettos,

Shopify has the industry leading tools to help you create, control and grow your own business.

So get serious about selling and get Shopify today.

Sign up for a £1 per month trial period at Shopify.com.

com slash special offer or lowercase.

That's Shopify.com.com slash special offer or lowercase. That's Shopify.comdee slash special offer.

I've got to say I'm growing a little concerned about these semi-glutides and the ubiquitous nature of them,

how many people are taking them, how they're now being given to children, how they're now even being recommended for people who aren't

really obese, but maybe could be or are perhaps a few pounds overweight.

I hope in the end, after all the evaluation, it turns out that the benefits for most people

far, far outweigh any risks, and that may still be the case. The FDA should be

engaged in ongoing evaluation of these matters because side effects of drugs are typically not

known in full for years until many people have been taking them for quite some time. A lot of the

side effects that will eventually go on the label of a drug

are side effects that didn't show up in the original clinical trials. So it's sort of a learning curve

those years after a drug is approved as it's taken by so many people. And while a lot of people have a lot

of hope for Ozympic, Wee Govi, and perhaps other drugs that will be developed like them,

...